Ninomiya T, Ohara T, Hirakawa Y, Yoshida D, Doi Y, Hata J, et al. Midlife and late-life blood pressure and dementia in Japanese elderly: the Hisayama study. Hypertension. 2011;58(1):22–8. https://doi.org/10.1161/HYPERTENSIONAHA.110.163055.
Article
CAS
PubMed
Google Scholar
Xu W, Qiu C, Gatz M, Pedersen NL, Johansson B, Fratiglioni L. Mid- and late-life diabetes in relation to the risk of dementia: a population-based twin study. Diabetes. 2009;58(1):71–7. https://doi.org/10.2337/db08-0586.
Article
CAS
PubMed
PubMed Central
Google Scholar
Luchsinger JA, Cheng D, Tang MX, Schupf N, Mayeux R. Central obesity in the elderly is related to late-onset Alzheimer disease. Alzheimer Dis Assoc Disord. 2012;26(2):101–5. https://doi.org/10.1097/WAD.0b013e318222f0d4.
Article
PubMed
PubMed Central
Google Scholar
Xue-Shan Z, Juan P, Qi W, Zhong R, Li-Hong P, Zhi-Han T, et al. Imbalanced cholesterol metabolism in Alzheimer’s disease. Clin Chim Acta. 2016;456:107–14. https://doi.org/10.1016/j.cca.2016.02.024.
Article
CAS
PubMed
Google Scholar
Ho RC, Niti M, Yap KB, Kua EH, Ng TP. Metabolic syndrome and cognitive decline in chinese older adults: results from the singapore longitudinal ageing studies. Am J Geriatr Psychiatry. 2008;16(6):519–22. https://doi.org/10.1097/JGP.0b013e31816b7841.
Article
PubMed
Google Scholar
van den Berg E, Biessels GJ, de Craen AJ, Gussekloo J, Westendorp RG. The metabolic syndrome is associated with decelerated cognitive decline in the oldest old. Neurology. 2007;69(10):979–85. https://doi.org/10.1212/01.wnl.0000271381.30143.75.
Article
CAS
PubMed
Google Scholar
Muller M, Tang MX, Schupf N, Manly JJ, Mayeux R, Luchsinger JA. Metabolic syndrome and dementia risk in a multiethnic elderly cohort. Dement Geriatr Cogn Disord. 2007;24(3):185–92. https://doi.org/10.1159/000105927.
Article
PubMed
Google Scholar
Atti AR, Valente S, Iodice A, Caramella I, Ferrari B, Albert U, et al. Metabolic syndrome, mild cognitive impairment, and dementia: a meta-analysis of longitudinal studies. Am J Geriatr Psychiatry. 2019;27(6):625–37. https://doi.org/10.1016/j.jagp.2019.01.214.
Article
PubMed
Google Scholar
Forti P, Pisacane N, Rietti E, Lucicesare A, Olivelli V, Mariani E, et al. Metabolic syndrome and risk of dementia in older adults. J Am Geriatr Soc. 2010;58(3):487–92. https://doi.org/10.1111/j.1532-5415.2010.02731.x.
Article
PubMed
Google Scholar
Xu W, Tan L, Wang HF, Jiang T, Tan MS, Tan L, et al. Meta-analysis of modifiable risk factors for Alzheimer’s disease. J Neurol Neurosurg Psychiatry. 2015;86(12):1299–306. https://doi.org/10.1136/jnnp-2015-310548.
Article
PubMed
Google Scholar
Kalaria RN, Maestre GE, Arizaga R, Friedland RP, Galasko D, Hall K, et al. Alzheimer’s disease and vascular dementia in developing countries: prevalence, management, and risk factors. Lancet Neurol. 2008;7(9):812–26. https://doi.org/10.1016/s1474-4422(08)70169-8.
Article
PubMed
PubMed Central
Google Scholar
Rizzi L, Rosset I, Roriz-Cruz M. Global epidemiology of dementia: Alzheimer’s and vascular types. Biomed Res Int. 2014;2014:908915. https://doi.org/10.1155/2014/908915.
Article
PubMed
PubMed Central
Google Scholar
Choi JB, Lee EJ, Han KD, Hong SH, Ha US. Estimating the impact of body mass index on bladder cancer risk: Stratification by smoking status. Sci Rep. 2018;8(1):947. https://doi.org/10.1038/s41598-018-19531-7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Song SO, Jung CH, Song YD, Park CY, Kwon HS, Cha BS, et al. Background and data configuration process of a nationwide population-based study using the korean national health insurance system. Diabetes Metab J. 2014;38(5):395–403. https://doi.org/10.4093/dmj.2014.38.5.395.
Article
PubMed
PubMed Central
Google Scholar
Lee SR, Choi EK, Han KD, Cha MJ, Oh S. Trends in the incidence and prevalence of atrial fibrillation and estimated thromboembolic risk using the CHA2DS2-VASc score in the entire Korean population. Int J Cardiol. 2017;236:226–31. https://doi.org/10.1016/j.ijcard.2017.02.039.
Article
PubMed
Google Scholar
Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640–5. https://doi.org/10.1161/CIRCULATIONAHA.109.192644.
Article
CAS
PubMed
Google Scholar
Luque-Contreras D, Carvajal K, Toral-Rios D, Franco-Bocanegra D, Campos-Pena V. Oxidative stress and metabolic syndrome: cause or consequence of Alzheimer’s disease? Oxid Med Cell Longev. 2014;2014:497802. https://doi.org/10.1155/2014/497802.
Article
CAS
PubMed
PubMed Central
Google Scholar
Calvillo M, Diaz A, Limon DI, Mayoral MA, Chanez-Cardenas ME, Zenteno E, et al. Amyloid-beta(25–35) induces a permanent phosphorylation of HSF-1, but a transitory and inflammation-independent overexpression of Hsp-70 in C6 astrocytoma cells. Neuropeptides. 2013;47(5):339–46. https://doi.org/10.1016/j.npep.2013.06.002.
Article
CAS
PubMed
Google Scholar
Minter MR, Taylor JM, Crack PJ. The contribution of neuroinflammation to amyloid toxicity in Alzheimer’s disease. J Neurochem. 2016;136(3):457–74. https://doi.org/10.1111/jnc.13411.
Article
CAS
PubMed
Google Scholar
Blasko I, Stampfer-Kountchev M, Robatscher P, Veerhuis R, Eikelenboom P, Grubeck-Loebenstein B. How chronic inflammation can affect the brain and support the development of Alzheimer’s disease in old age: the role of microglia and astrocytes. Aging Cell. 2004;3(4):169–76. https://doi.org/10.1111/j.1474-9728.2004.00101.x.
Article
CAS
PubMed
Google Scholar
Milionis HJ, Florentin M, Giannopoulos S. Metabolic syndrome and Alzheimer’s disease: a link to a vascular hypothesis? CNS Spectr. 2008;13(7):606–13. https://doi.org/10.1017/s1092852900016886.
Article
PubMed
Google Scholar
Nasoohi S, Parveen K, Ishrat T. Metabolic syndrome, brain insulin resistance, and Alzheimer’s disease: thioredoxin interacting protein (txnip) and inflammasome as core amplifiers. J Alzheimers Dis. 2018;66(3):857–85. https://doi.org/10.3233/JAD-180735.
Article
CAS
PubMed
Google Scholar
Razay G, Vreugdenhil A, Wilcock G. The metabolic syndrome and Alzheimer disease. Arch Neurol. 2007;64(1):93–6. https://doi.org/10.1001/archneur.64.1.93.
Article
PubMed
Google Scholar
Vanhanen M, Koivisto K, Moilanen L, Helkala EL, Hanninen T, Soininen H, et al. Association of metabolic syndrome with Alzheimer disease: a population-based study. Neurology. 2006;67(5):843–7. https://doi.org/10.1212/01.wnl.0000234037.91185.99.
Article
CAS
PubMed
Google Scholar
Kalmijn S, Foley D, White L, Burchfiel CM, Curb JD, Petrovitch H, et al. Metabolic cardiovascular syndrome and risk of dementia in Japanese-American elderly men. The Honolulu-Asia aging study. Arterioscler Thromb Vasc Biol. 2000;20(10):2255–60. https://doi.org/10.1161/01.atv.20.10.2255.
Article
CAS
PubMed
Google Scholar
Raffaitin C, Gin H, Empana JP, Helmer C, Berr C, Tzourio C, et al. Metabolic syndrome and risk for incident Alzheimer’s disease or vascular dementia: the Three-City Study. Diabetes Care. 2009;32(1):169–74. https://doi.org/10.2337/dc08-0272.
Article
PubMed
PubMed Central
Google Scholar
Solfrizzi V, Scafato E, Capurso C, D’Introno A, Colacicco AM, Frisardi V, et al. Metabolic syndrome and the risk of vascular dementia: the Italian Longitudinal Study on Ageing. J Neurol Neurosurg Psychiatry. 2010;81(4):433–40. https://doi.org/10.1136/jnnp.2009.181743.
Article
PubMed
Google Scholar
Feinkohl I, Janke J, Hadzidiakos D, Slooter A, Winterer G, Spies C, et al. Associations of the metabolic syndrome and its components with cognitive impairment in older adults. BMC Geriatr. 2019;19(1):77. https://doi.org/10.1186/s12877-019-1073-7.
Article
PubMed
PubMed Central
Google Scholar
Cooper C, Sommerlad A, Lyketsos CG, Livingston G. Modifiable predictors of dementia in mild cognitive impairment: a systematic review and meta-analysis. Am J Psychiatry. 2015;172(4):323–34. https://doi.org/10.1176/appi.ajp.2014.14070878.
Article
PubMed
Google Scholar
Bangen KJ, Armstrong NM, Au R, Gross AL. Metabolic syndrome and cognitive trajectories in the framingham offspring study. J Alzheimers Dis. 2019;71(3):931–43. https://doi.org/10.3233/JAD-190261.
Article
PubMed
Google Scholar
Pendse AA, Arbones-Mainar JM, Johnson LA, Altenburg MK, Maeda N. Apolipoprotein E knock-out and knock-in mice: atherosclerosis, metabolic syndrome, and beyond. J Lipid Res. 2009;50(Suppl):S178–82. https://doi.org/10.1194/jlr.R800070-JLR200.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sanan DA, Weisgraber KH, Russell SJ, Mahley RW, Huang D, Saunders A, et al. Apolipoprotein E associates with beta amyloid peptide of Alzheimer’s disease to form novel monofibrils Isoform apoE4 associates more efficiently than apoE3. J Clin Invest. 1994;94(2):860–9. https://doi.org/10.1172/JCI117407.
Article
CAS
PubMed
PubMed Central
Google Scholar
Brandon JA, Farmer BC, Williams HC, Johnson LA. APOE and Alzheimer’s disease: neuroimaging of metabolic and cerebrovascular dysfunction. Front Aging Neurosci. 2018;10:180. https://doi.org/10.3389/fnagi.2018.00180.
Article
CAS
PubMed
PubMed Central
Google Scholar
van den Berg E, Kloppenborg RP, Kessels RP, Kappelle LJ, Biessels GJ. Type 2 diabetes mellitus, hypertension, dyslipidemia and obesity: A systematic comparison of their impact on cognition. Biochim Biophys Acta. 2009;1792(5):470–81. https://doi.org/10.1016/j.bbadis.2008.09.004.
Article
CAS
PubMed
Google Scholar
Power MC, Rawlings A, Sharrett AR, Bandeen-Roche K, Coresh J, Ballantyne CM, et al. Association of midlife lipids with 20-year cognitive change: a cohort study. Alzheimers Dement. 2018;14(2):167–77. https://doi.org/10.1016/j.jalz.2017.07.757.
Article
PubMed
Google Scholar
Reitz C, Tang MX, Luchsinger J, Mayeux R. Relation of plasma lipids to Alzheimer disease and vascular dementia. Arch Neurol. 2004;61(5):705–14. https://doi.org/10.1001/archneur.61.5.705.
Article
PubMed
PubMed Central
Google Scholar
Pedditzi E, Peters R, Beckett N. The risk of overweight/obesity in mid-life and late life for the development of dementia: a systematic review and meta-analysis of longitudinal studies. Age Ageing. 2016;45(1):14–21. https://doi.org/10.1093/ageing/afv151.
Article
PubMed
Google Scholar
Fan YC, Hsu JL, Tung HY, Chou CC, Bai CH. Increased dementia risk predominantly in diabetes mellitus rather than in hypertension or hyperlipidemia: a population-based cohort study. Alzheimers Res Ther. 2017;9(1):7. https://doi.org/10.1186/s13195-017-0236-z.
Article
CAS
PubMed
PubMed Central
Google Scholar
Levin BE, Llabre MM, Dong C, Elkind MS, Stern Y, Rundek T, et al. Modeling metabolic syndrome and its association with cognition: the Northern Manhattan study. J Int Neuropsychol Soc. 2014;20(10):951–60. https://doi.org/10.1017/S1355617714000861.
Article
PubMed
PubMed Central
Google Scholar
Jendroska K, Poewe W, Daniel SE, Pluess J, Iwerssen-Schmidt H, Paulsen J, et al. Ischemic stress induces deposition of amyloid beta immunoreactivity in human brain. Acta Neuropathol. 1995;90(5):461–6. https://doi.org/10.1007/BF00294806.
Article
CAS
PubMed
Google Scholar
Riekse RG, Leverenz JB, McCormick W, Bowen JD, Teri L, Nochlin D, et al. Effect of vascular lesions on cognition in Alzheimer’s disease: a community-based study. J Am Geriatr Soc. 2004;52(9):1442–8. https://doi.org/10.1111/j.1532-5415.2004.52405.x.
Article
PubMed
PubMed Central
Google Scholar
Gomez G, Beason-Held LL, Bilgel M, An Y, Wong DF, Studenski S, et al. Metabolic syndrome and amyloid accumulation in the aging brain. J Alzheimers Dis. 2018;65(2):629–39. https://doi.org/10.3233/JAD-180297.
Article
CAS
PubMed
PubMed Central
Google Scholar
Xue M, Xu W, Ou YN, Cao XP, Tan MS, Tan L, et al. Diabetes mellitus and risks of cognitive impairment and dementia: a systematic review and meta-analysis of 144 prospective studies. Ageing Res Rev. 2019;55:100944. https://doi.org/10.1016/j.arr.2019.100944.
Article
CAS
PubMed
Google Scholar
Crane PK, Walker R, Hubbard RA, Li G, Nathan DM, Zheng H, et al. Glucose levels and risk of dementia. N Engl J Med. 2013;369(6):540–8. https://doi.org/10.1056/NEJMoa1215740.
Article
CAS
PubMed
PubMed Central
Google Scholar
Li X, Song D, Leng SX. Link between type 2 diabetes and Alzheimer’s disease: from epidemiology to mechanism and treatment. Clin Interv Aging. 2015;10:549–60. https://doi.org/10.2147/CIA.S74042.
Article
PubMed
PubMed Central
Google Scholar
Tamura Y, Araki A. Diabetes mellitus and white matter hyperintensity. Geriatr Gerontol Int. 2015;15(Suppl 1):34–42. https://doi.org/10.1111/ggi.12666.
Article
PubMed
Google Scholar
Yang R, Pedersen NL, Bao C, Xu W, Xu H, Song R, et al. Type 2 diabetes in midlife and risk of cerebrovascular disease in late life: a prospective nested case-control study in a nationwide Swedish twin cohort. Diabetologia. 2019;62(8):1403–11. https://doi.org/10.1007/s00125-019-4892-3.
Article
CAS
PubMed
PubMed Central
Google Scholar
Arboix A, Rivas A, Garcia-Eroles L, de Marcos L, Massons J, Oliveres M. Cerebral infarction in diabetes: clinical pattern, stroke subtypes, and predictors of in-hospital mortality. BMC Neurol. 2005;5(1):9. https://doi.org/10.1186/1471-2377-5-9.
Article
PubMed
PubMed Central
Google Scholar
Moloney AM, Griffin RJ, Timmons S, O’Connor R, Ravid R, O’Neill C. Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer’s disease indicate possible resistance to IGF-1 and insulin signalling. Neurobiol Aging. 2010;31(2):224–43. https://doi.org/10.1016/j.neurobiolaging.2008.04.002.
Article
CAS
PubMed
Google Scholar
Gerozissis K. Brain insulin, energy and glucose homeostasis; genes, environment and metabolic pathologies. Eur J Pharmacol. 2008;585(1):38–49. https://doi.org/10.1016/j.ejphar.2008.01.050.
Article
CAS
PubMed
Google Scholar
Unger J, McNeill TH, Moxley RT, White M, Moss A, Livingston JN. Distribution of insulin receptor-like immunoreactivity in the rat forebrain. Neuroscience. 1989;31(1):143–57. https://doi.org/10.1016/0306-4522(89)90036-5.
Article
CAS
PubMed
Google Scholar
Cipolla MJ, Liebeskind DS, Chan SL. The importance of comorbidities in ischemic stroke: impact of hypertension on the cerebral circulation. J Cereb Blood Flow Metab. 2018;38(12):2129–49. https://doi.org/10.1177/0271678X18800589.
Article
PubMed
PubMed Central
Google Scholar
Sacco RL, Benson RT, Kargman DE, Boden-Albala B, Tuck C, Lin IF, et al. High-density lipoprotein cholesterol and ischemic stroke in the elderly: the Northern Manhattan Stroke Study. JAMA. 2001;285(21):2729–35. https://doi.org/10.1001/jama.285.21.2729.
Article
CAS
PubMed
Google Scholar
Suk SH, Sacco RL, Boden-Albala B, Cheun JF, Pittman JG, Elkind MS, et al. Abdominal obesity and risk of ischemic stroke: the Northern Manhattan Stroke Study. Stroke. 2003;34(7):1586–92. https://doi.org/10.1161/01.STR.0000075294.98582.2F.
Article
PubMed
Google Scholar
Frisardi V, Solfrizzi V, Capurso C, Imbimbo BP, Vendemiale G, Seripa D, et al. Is insulin resistant brain state a central feature of the metabolic-cognitive syndrome? J Alzheimers Dis. 2010;21(1):57–63. https://doi.org/10.3233/JAD-2010-100015.
Article
CAS
PubMed
Google Scholar
Chi NF, Chien LN, Ku HL, Hu CJ, Chiou HY. Alzheimer disease and risk of stroke: a population-based cohort study. Neurology. 2013;80(8):705–11. https://doi.org/10.1212/WNL.0b013e31828250af.
Article
PubMed
Google Scholar
Gamaldo A, Moghekar A, Kilada S, Resnick SM, Zonderman AB, O’Brien R. Effect of a clinical stroke on the risk of dementia in a prospective cohort. Neurology. 2006;67(8):1363–9. https://doi.org/10.1212/01.wnl.0000240285.89067.3f.
Article
CAS
PubMed
Google Scholar
Allan LM, Rowan EN, Firbank MJ, Thomas AJ, Parry SW, Polvikoski TM, et al. Long term incidence of dementia, predictors of mortality and pathological diagnosis in older stroke survivors. Brain. 2011;134(Pt 12):3716–27. https://doi.org/10.1093/brain/awr273.
Article
PubMed
Google Scholar
Xing C, Arai K, Lo EH, Hommel M. Pathophysiologic cascades in ischemic stroke. Int J Stroke. 2012;7(5):378–85. https://doi.org/10.1111/j.1747-4949.2012.00839.x.
Article
PubMed
PubMed Central
Google Scholar
Vijayan M, Kumar S, Bhatti JS, Reddy PH. Molecular links and biomarkers of stroke, vascular dementia, and Alzheimer’s disease. Prog Mol Biol Transl Sci. 2017;146:95–126. https://doi.org/10.1016/bs.pmbts.2016.12.014.
Article
CAS
PubMed
Google Scholar
Snowdon DA. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA J Am Med Assoc. 1997;277:10. https://doi.org/10.1001/jama.1997.03540340047031.
Article
Google Scholar
Esiri MM, Nagy Z, Smith MZ, Barnetson L, Smith AD. Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer’s disease. Lancet. 1999;354(9182):919–20. https://doi.org/10.1016/s0140-6736(99)02355-7.
Article
CAS
PubMed
Google Scholar
Kalaria RN, Akinyemi R, Ihara M. Does vascular pathology contribute to Alzheimer changes? J Neurol Sci. 2012;322(1–2):141–7. https://doi.org/10.1016/j.jns.2012.07.032.
Article
CAS
PubMed
Google Scholar
Regan C, Katona C, Walker Z, Hooper J, Donovan J, Livingston G. Relationship of vascular risk to the progression of Alzheimer disease. Neurology. 2006;67(8):1357–62. https://doi.org/10.1212/01.wnl.0000240129.46080.53.
Article
CAS
PubMed
Google Scholar
Pendlebury ST, Rothwell PM. Incidence and prevalence of dementia associated with transient ischaemic attack and stroke: analysis of the population-based Oxford Vascular Study. Lancet Neurol. 2019;18(3):248–58. https://doi.org/10.1016/s1474-4422(18)30442-3.
Article
PubMed
PubMed Central
Google Scholar
Stevens J, Cai J, Pamuk ER, Williamson DF, Thun MJ, Wood JL. The effect of age on the association between body-mass index and mortality. N Engl J Med. 1998;338(1):1–7. https://doi.org/10.1056/NEJM199801013380101.
Article
CAS
PubMed
Google Scholar
Rankinen T, Kim SY, Perusse L, Despres JP, Bouchard C. The prediction of abdominal visceral fat level from body composition and anthropometry: ROC analysis. Int J Obes Relat Metab Disord. 1999;23(8):801–9. https://doi.org/10.1038/sj.ijo.0800929.
Article
CAS
PubMed
Google Scholar
Harvey J, Solovyova N, Irving A. Leptin and its role in hippocampal synaptic plasticity. Prog Lipid Res. 2006;45(5):369–78. https://doi.org/10.1016/j.plipres.2006.03.001.
Article
CAS
PubMed
PubMed Central
Google Scholar
Marseglia L, Manti S, D’Angelo G, Nicotera A, Parisi E, Di Rosa G, et al. Oxidative stress in obesity: a critical component in human diseases. Int J Mol Sci. 2014;16(1):378–400. https://doi.org/10.3390/ijms16010378.
Article
CAS
PubMed
PubMed Central
Google Scholar
Moh MC, Low S, Ng TP, Wang J, Ang SF, Tan C, et al. Association of traditional and novel measures of central obesity with cognitive performance in older multi-ethnic Asians with type 2 diabetes. Clin Obes. 2020;10(2):e12352. https://doi.org/10.1111/cob.12352.
Article
PubMed
Google Scholar
Beydoun MA, Beydoun HA, Wang Y. Obesity and central obesity as risk factors for incident dementia and its subtypes: a systematic review and meta-analysis. Obes Rev. 2008;9(3):204–18. https://doi.org/10.1111/j.1467-789X.2008.00473.x.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tanner CM. Advances in environmental epidemiology. Mov Disord. 2010;25(Suppl 1):S58-62. https://doi.org/10.1002/mds.22721.
Article
PubMed
Google Scholar
Fahn S. Parkinson’s disease: 10 years of progress, 1997–2007. Mov Disord. 2010;25(Suppl 1):S2-14. https://doi.org/10.1002/mds.22796.
Article
PubMed
Google Scholar
Nicoletti A, Pugliese P, Nicoletti G, Arabia G, Annesi G, Mari MD, et al. Voluptuary habits and clinical subtypes of Parkinson’s disease: the FRAGAMP case-control study. Mov Disord. 2010;25(14):2387–94. https://doi.org/10.1002/mds.23297.
Article
PubMed
Google Scholar
Picciotto MR, Zoli M. Neuroprotection via nAChRs: the role of nAChRs in neurodegenerative disorders such as Alzheimer’s and Parkinson’s disease. Front Biosci. 2008;13:492–504. https://doi.org/10.2741/2695.
Article
CAS
PubMed
Google Scholar
Quik M, Perez XA, Bordia T. Nicotine as a potential neuroprotective agent for Parkinson’s disease. Mov Disord. 2012;27(8):947–57. https://doi.org/10.1002/mds.25028.
Article
CAS
PubMed
PubMed Central
Google Scholar
Deckers K, van Boxtel MP, Schiepers OJ, de Vugt M, Munoz Sanchez JL, Anstey KJ, et al. Target risk factors for dementia prevention: a systematic review and Delphi consensus study on the evidence from observational studies. Int J Geriatr Psychiatry. 2015;30(3):234–46. https://doi.org/10.1002/gps.4245.
Article
PubMed
Google Scholar
Collins N, Sachs-Ericsson N, Preacher KJ, Sheffield KM, Markides K. Smoking increases risk for cognitive decline among community-dwelling older Mexican Americans. Am J Geriatr Psychiatry. 2009;17(11):934–42. https://doi.org/10.1097/JGP.0b013e3181b0f8df.
Article
PubMed
PubMed Central
Google Scholar
Rusanen M, Rovio S, Ngandu T, Nissinen A, Tuomilehto J, Soininen H, et al. Midlife smoking, apolipoprotein E and risk of dementia and Alzheimer’s disease: a population-based cardiovascular risk factors, aging and dementia study. Dement Geriatr Cogn Disord. 2010;30(3):277–84. https://doi.org/10.1159/000320484.
Article
CAS
PubMed
Google Scholar
Calderon-Garciduenas L. Smoking and cerebral oxidative stress and air pollution: a dreadful equation with particulate matter involved and one more powerful reason not to smoke anything! J Alzheimers Dis. 2016;54(1):109–12. https://doi.org/10.3233/JAD-160510.
Article
CAS
PubMed
Google Scholar
Gerzanich V, Zhang F, West GA, Simard JM. Chronic nicotine alters NO signaling of Ca(2+) channels in cerebral arterioles. Circ Res. 2001;88(3):359–65. https://doi.org/10.1161/01.res.88.3.359.
Article
CAS
PubMed
Google Scholar
Wang P, Li B, Cai G, Huang M, Jiang L, Pu J, et al. Activation of PPAR-gamma by pioglitazone attenuates oxidative stress in aging rat cerebral arteries through upregulating UCP2. J Cardiovasc Pharmacol. 2014;64(6):497–506. https://doi.org/10.1097/FJC.0000000000000143.
Article
CAS
PubMed
Google Scholar
Toda N, Okamura T. Cigarette smoking impairs nitric oxide-mediated cerebral blood flow increase: implications for Alzheimer’s disease. J Pharmacol Sci. 2016;131(4):223–32. https://doi.org/10.1016/j.jphs.2016.07.001.
Article
CAS
PubMed
Google Scholar
Durazzo TC, Mattsson N, Weiner MW. Alzheimer’s Disease Neuroimaging I Smoking and increased Alzheimer’s disease risk: a review of potential mechanisms. Alzheimers Dement. 2014;10(3 Suppl):S122–45. https://doi.org/10.1016/j.jalz.2014.04.009.
Article
PubMed
PubMed Central
Google Scholar